Found: 5
Select item for more details and to access through your institution.
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 741, doi. 10.1007/s10549-020-05991-x
- By:
- Publication type:
- Article
Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 2, p. 413, doi. 10.1007/s10549-017-4601-1
- By:
- Publication type:
- Article
Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 1, p. 1, doi. 10.1093/jnci/djx134
- By:
- Publication type:
- Article
Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 3, p. 349, doi. 10.3109/0284186X.2014.964809
- By:
- Publication type:
- Article
Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 5, p. 1181, doi. 10.1002/ijc.33700
- By:
- Publication type:
- Article